Skip to main content
Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.9600
-0.0250 (-2.54%)
At close: Nov 13, 2026, 4:00 PM EST
1.010
+0.050 (5.21%)
After-hours: Nov 13, 2026, 7:29 PM EST

Acurx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.1-7.97-14.1-14.58-12.09-12.75
Stock-Based Compensation
1.271.573.443.773.36.07
Other Operating Activities
-----1.52
Change in Accounts Payable
0.53-0.410.20.981.220.39
Change in Other Net Operating Assets
-0.480.020.080.030.03-0.25
Operating Cash Flow
-6.79-6.79-10.38-9.8-7.54-5.01
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
10.6810.786.628.163.714.8
Other Financing Activities
-0.14-0.15----
Financing Cash Flow
10.5410.646.628.163.714.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3.753.85-3.77-1.64-3.859.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-4.51-4.29-5.11-4.33-3.01-0.21
Unlevered Free Cash Flow
-4.51-4.29-5.11-4.33-3.01-0.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.04-0.390.281.011.250.14
SEC Filings: 10-K · 10-Q